|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5A
|
|
pubmed:dateCreated |
2003-12-11
|
|
pubmed:abstractText |
We have previously found cyclin D1 to be overexpressed in 45% of corpus cancers, but in only 3% of cervical cancers. To see whether and how D-type cyclins contribute to the neoplastic phenotype in uterine cancers, aberrant expression and association between cyclins D1 and D3 proteins were studied.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0250-7005
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
23
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3929-35
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:14666699-Cyclin D1,
pubmed-meshheading:14666699-Cyclin D3,
pubmed-meshheading:14666699-Cyclins,
pubmed-meshheading:14666699-Female,
pubmed-meshheading:14666699-Gene Dosage,
pubmed-meshheading:14666699-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:14666699-Humans,
pubmed-meshheading:14666699-Immunohistochemistry,
pubmed-meshheading:14666699-In Situ Hybridization, Fluorescence,
pubmed-meshheading:14666699-Ki-67 Antigen,
pubmed-meshheading:14666699-Uterine Cervical Neoplasms,
pubmed-meshheading:14666699-Uterine Neoplasms
|
|
pubmed:articleTitle |
Deregulation of D-type cyclins in uterine cancers. Cyclin D1/D3 is differentially expressed in cervical cancer.
|
|
pubmed:affiliation |
Department of Pathology, Norwegian Radium Hospital, Oslo, Norway.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
